Latest Mastocytoma Stories
SAN MARINO, Calif., Sept. 7 /PRNewswire/ -- Epeius Biotechnologies Corporation, a leader in the emerging field of targeted genetic medicine, reports the publication of a landmark paper in clinical oncology. Following up on its advanced U.S.
EPFL study reveals importance of relation between the lymphatic system and tumors.
BREA, Calif., Oct. 29 /PRNewswire/ -- Cancer is not strictly a "human" condition. As the No. 1 disease-related killer of dogs and cats, cancer claims millions of pets each year. This November, Veterinary Pet Insurance Co.
ABBOTT PARK, Ill. and UPPSALA, Sweden, July 10 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) and Oasmia Pharmaceutical have announced a multi-year agreement to market one of the first cancer medications for dogs.
The US Food and Drug Administration has approved Pfizer Incâ€™s Palladia, a cancer treatment drug designed for dogs.
By Patnaik, Mrinal M; Rindos, Michelle; Kouides, Peter A; Tefferi, Ayalew; Pardanani, Animesh Context.-Systemic mastocytosis is characterized by abnormal growth and accumulation of neoplastic mast cells in various organs.
Virginia Commonwealth University immunologists studying mast cells, known to play a central role in asthma and allergic disease, have identified a hormone-like molecule that can kill these cells by programming them to die in studies with mice.
- totally perplexed and mixed up.